Eliminating Drug Target Interference with Specific Antibody or its F(ab′) <sub>2</sub> Fragment in the Bridging Immunogenicity Assay-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eliminating Drug Target Interference with Specific Antibody or its F(ab′) ₂ Fragment in the Bridging Immunogenicity Assay

Published:2024-02-22 Issue:7 Volume:16 Page:135-148
ISSN:1757-6180
Container-title:Bioanalysis
language:en
Short-container-title:Bioanalysis

Author:

Deng Xiaojie¹,Hou Yingying¹²,Yuan Wenyi¹,Yang Hongzhou³,Guo Ruowen³,Liu Tingting¹²,Liu Yongzhen¹,Xu Junjiu¹,Liu Heng³,Gong Likun¹²⁴,Qin Qiuping¹²^ORCID

Affiliation:

1. Center for Drug Safety Evaluation and Research Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, 201203, China

2. State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences, Shanghai, 201203, China

3. Longbio Pharma (Suzhou) Co., Ltd, Suzhou, 215558, China

4. School of Pharmacy University of Chinese Academy of Sciences, Beijing, 100049, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.4155/bio-2023-0191

Reference24 articles.

1. Identification of IgE

2. The discovery of IgE

3. From IgE to Omalizumab

4. Immunogenicity of therapeutic proteins: Clinical implications and future prospects

5. Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP